Australia - English - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 12 mg (equivalent: noradrenaline (norepinephrine), qty 6 mg) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sumpathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

Australia - English - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 10 mg (equivalent: noradrenaline (norepinephrine), qty 5 mg) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sumpathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

Australia - English - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 6 mg (equivalent: noradrenaline (norepinephrine), qty 3 mg) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 4mg/1ml solution for infusion ampoules (special order - noradrenaline acid tartrate - solution for infusion - 4mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 4mg/2ml solution for infusion ampoules (special order - noradrenaline acid tartrate - solution for infusion - 2mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 5mg/5ml solution for infusion ampoules (special order - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 8mg/1ml solution for infusion ampoules (special order - noradrenaline acid tartrate - solution for infusion - 8mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 1mg/1ml solution for infusion ampoules (special order - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 10mg/10ml solution for infusion ampoules (special order - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 10mg/10ml concentrate for solution for infusion ampoules (as kalceks - noradrenaline acid tartrate - solution for infusion - 1mg/1ml